Compare FedEx Corporation (FDX) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FedEx Corporation vs Nuwellis Inc — how do they compare? FedEx Corporation trades at $292.3 (market cap $68.41B), while Nuwellis Inc trades at $0.68 (market cap $2.20M). The key difference: FedEx Corporation is far larger — about 31095.5× Nuwellis Inc's market cap, and FedEx Corporation pays a 1.69% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold FedEx Corporation for 87 Days and Nuwellis Inc for 26 Days on average.
| FDX | NUWE | |
|---|---|---|
Market Cap | $68.41B | $2.20M |
Volume | 1,232,551 | 121,544 |
Sector | Industrials | Health |
52-Week High | $339.35 | $146.65 |
52-Week Low | $180.87 | $0.68 |
Typical Hold Time | 87 Days | 26 Days |
Enterprise Value | $98.04B | -$1.52M |
Dividend Yield | 1.69% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FDX trades at $289.04, flat on the day, with a bearish technical signal from moving averages and ADX indicators. The company reported revenue of $87.93B for 2025, with a net income margin of 4.68% and a P/E ratio of 15.58. Recent news includes a $300 million order for electric trucks from Harbinger and shareholder approval of executive compensation at the annual meeting.
The outlook is mixed, with strong analyst buy consensus (57%) and a price target of $307.55 offering upside potential, but risks from rising fuel costs and a bearish technical trend suggest near-term volatility. Earnings beats in recent quarters support fundamental strength, yet macroeconomic pressures on logistics margins warrant caution.
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About FedEx Corporation
FedEx pioneered overnight delivery in 1973 and remains the world's largest express package provider. In its fiscal 2020 (ended May 2020), FedEx derived 51% of revenue from its express division, 33% from ground, and 10% from freight, its asset-based less-than-truckload shipping segment. The remainder comes from other services, including FedEx Office, which provides document production/shipping, and FedEx Logistics, which provides global forwarding. FedEx acquired Dutch parcel delivery firm TNT Express in 2016. TNT was previously the fourth-largest global parcel delivery provider.
Read more on FDX →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
